{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:15:54Z","timestamp":1783188954264,"version":"3.54.6"},"reference-count":94,"publisher":"Elsevier","isbn-type":[{"value":"9780443415470","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017171","name":"Institut Catal\u00e0 de Nanoci\u00e8ncia i Nanotecnologia","doi-asserted-by":"publisher","award":["IN2UB"],"award-info":[{"award-number":["IN2UB"]}],"id":[{"id":"10.13039\/100017171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017171","name":"Institut Catal\u00e0 de Nanoci\u00e8ncia i Nanotecnologia","doi-asserted-by":"publisher","award":["2025IG105183WI"],"award-info":[{"award-number":["2025IG105183WI"]}],"id":[{"id":"10.13039\/100017171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2024\\u2013157231OB-C21"],"award-info":[{"award-number":["PID2024\\u2013157231OB-C21"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apha.2026.03.002","type":"book-chapter","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:29:49Z","timestamp":1777030189000},"page":"325-363","source":"Crossref","is-referenced-by-count":0,"title":["Polymeric nanoparticles functionalized with peptides: Advanced strategies for crossing the blood\u2013brain barrier"],"prefix":"10.1016","author":[{"given":"X.","family":"Llorente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Esteruelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib1","first-page":"795","article-title":"Nanoscale drug delivery systems and the blood-brain barrier","volume":"9","author":"Alyautdin","year":"2014","journal-title":"International Journal of Nanomedicine"},{"issue":"4","key":"10.1016\/bs.apha.2026.03.002_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharma.2013.04.001","article-title":"Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: The example of Alzheimer\u2019s disease","volume":"71","author":"Andrieux","year":"2013","journal-title":"Annales Pharmaceutiques Fran\u00c7aises"},{"issue":"February","key":"10.1016\/bs.apha.2026.03.002_bib3","first-page":"1","article-title":"An insight to brain targeting utilizing polymeric nanoparticles: Effective treatment modalities for neurological disorders and brain tumor","volume":"10","author":"Annu","year":"2022","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"10.1016\/bs.apha.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejpb.2017.08.008","article-title":"Penetration of polymeric nanoparticles loaded with an HIV-1 inhibitor peptide derived from GB virus C in a vaginal mucosa model","volume":"120","author":"Ariza-S\u00e1enz","year":"2017","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood-brain barrier for effective treatment of Alzheimer\u2019s disease","volume":"18","author":"Arora","year":"2021","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.03.002_bib6","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.3390\/molecules18089531","article-title":"Alkyne-Azide \u201cClick\u201d chemistry in designing nanocarriers for applications in biology","author":"Avti","year":"2013","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020224","article-title":"An overview of nanotechnologies for drug delivery to the brain","volume":"14","author":"Ayub","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: An overview: Structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apha.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-0-387-72573-4_4","article-title":"The blood brain barrier","author":"Banks","year":"2008","journal-title":"Neuroimmune Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1021\/acs.jmedchem.0c01399","article-title":"Cellular internalization and inhibition capacity of new anti-glioma peptide conjugates: Physicochemical characterization and evaluation on various monolayer- and 3D-spheroid-based in vitro platforms","volume":"64","author":"Baranyai","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.apha.2026.03.002_bib11","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chemical Reviews"},{"issue":"12","key":"10.1016\/bs.apha.2026.03.002_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122658","article-title":"Drug delivery to the brain: Recent advances and unmet challenges","volume":"15","author":"Bhunia","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1602\/neurorx.2.1.15","article-title":"How to measure drug transport across the blood-brain barrier","volume":"2","author":"Bickel","year":"2005","journal-title":"NeuroRx: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"S1","key":"10.1016\/bs.apha.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/epi4.12567","article-title":"Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges","volume":"7","author":"Bonilla","year":"2022","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsanm.0c02888","article-title":"Amphiphilic polymeric nanoparticles modified with a protease- resistant peptide shuttle for the delivery of SN-38 in diffuse intrinsic pontine glioma","volume":"4","author":"Bukchin","year":"2021","journal-title":"Acs Applied Nano Materials"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2010.10.025","article-title":"Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers","volume":"150","author":"Calderon","year":"2011","journal-title":"Journal of Controlled Release"},{"issue":"7","key":"10.1016\/bs.apha.2026.03.002_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jms.3224","article-title":"Understanding chemical reactivity for homo- and heterobifunctional protein cross-linking agents","volume":"48","author":"Chen","year":"2013","journal-title":"Journal of Mass Spectrometry"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of nanoparticles","volume":"25","author":"Choi","year":"2009","journal-title":"Nature Biotechnology"},{"issue":"50","key":"10.1016\/bs.apha.2026.03.002_bib19","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.1021\/acs.langmuir.8b02946","article-title":"Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy","volume":"34","author":"Clemons","year":"2018","journal-title":"Langmuir: the ACS Journal of Surfaces and Colloids"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02892-9","article-title":"Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium","volume":"22","author":"Cong","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"issue":"14","key":"10.1016\/bs.apha.2026.03.002_bib21","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1016\/j.jmb.2020.04.002","article-title":"A TfR-binding cystine-dense peptide promotes blood \u2013 brain barrier penetration of bioactive molecules","volume":"432","author":"Crook","year":"2020","journal-title":"Journal of Molecular Biology"},{"issue":"33","key":"10.1016\/bs.apha.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1016\/j.biomaterials.2013.07.075","article-title":"Biomaterials transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment","volume":"34","author":"Cui","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2194-0517-2-3","article-title":"An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery","volume":"2","author":"Donaldson","year":"2013","journal-title":"Progress in Biomaterials"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/bs.apha.2026.03.002_bib25","article-title":"Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence","volume":"28","author":"Duskey","year":"2020","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-008-9071-2","article-title":"Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment","volume":"11","author":"El-Sayed","year":"2009","journal-title":"AAPS Journal"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.002_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25102314","article-title":"Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals","volume":"25","author":"Evans","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.apha.2026.03.002_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102582","article-title":"Curcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies","volume":"300","author":"Feltrin","year":"2022","journal-title":"Advances in Colloid and Interface Science"},{"key":"10.1016\/bs.apha.2026.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-019-0391-z","article-title":"A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients","author":"Fujiwara","year":"2019","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.apha.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","article-title":"Smuggling drugs into the brain: An overview of ligands targeting transcytosis for drug delivery across the","volume":"6","author":"Georgieva","year":"2014","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1153568","article-title":"Nanoparticle transport across the blood brain barrier","volume":"4","author":"Grabrucker","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/bs.apha.2026.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102506","article-title":"Strategies and mechanisms for endosomal escape of therapeutic nucleic acids","volume":"81","author":"Grau","year":"2024","journal-title":"Current Opinion in Chemical Biology"},{"issue":"May 2025","key":"10.1016\/bs.apha.2026.03.002_bib33","article-title":"Nano today the landscape of nanomedical clinical trials","volume":"66","author":"Gultepe","year":"2026","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/bs.apha.2026.03.002_bib34","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1039\/C8BM01485J","article-title":"Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides","volume":"7","author":"Guo","year":"2019","journal-title":"Biomaterials Science"},{"issue":"January","key":"10.1016\/bs.apha.2026.03.002_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","article-title":"LRP1-upregulated nanoparticles for e ffi ciently conquering the blood-brain barrier and targetedly suppressing multifocal and in fi ltrative brain metastases","volume":"303","author":"Guo","year":"2019","journal-title":"Journal of Controlled Release"},{"issue":"August","key":"10.1016\/bs.apha.2026.03.002_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2020.08.010","article-title":"The influx\/efflux mechanisms of D-peptide ligand of nAChRs across the blood\u2013brain barrier and its therapeutic value in treating glioma","volume":"327","author":"Han","year":"2020","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apha.2026.03.002_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.pnpbp.2017.07.025","article-title":"Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory de fi cits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy","volume":"79","author":"Hashemian","year":"2017","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/bs.apha.2026.03.002_bib38","article-title":"Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes","volume":"11","author":"Heidarisasan","year":"2018","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2026.03.002_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-1759(99)00157-X","article-title":"High avidity scFv multimers; diabodies and triabodies","volume":"231","author":"Hudson","year":"1999","journal-title":"Journal of Immunological Methods"},{"issue":"9","key":"10.1016\/bs.apha.2026.03.002_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094486","article-title":"Alginate: Enhancement strategies for advanced applications","volume":"23","author":"Hurtado","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.002_bib41","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.xphs.2020.06.021","article-title":"Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity","volume":"109","author":"Islam","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0205-7","article-title":"Inhibition of \u03b2-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure\u2212activity relationship with a strong BBB permeability","volume":"51","author":"Jannat","year":"2019","journal-title":"Experimental and Molecular Medicine"},{"key":"10.1016\/bs.apha.2026.03.002_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2010.07.007","article-title":"Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies","volume":"76","author":"Joshi","year":"2010","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/bs.apha.2026.03.002_bib44","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","author":"Kanazawa","year":"2011","journal-title":"Pharmaceutical Research"},{"issue":"6","key":"10.1016\/bs.apha.2026.03.002_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01763-4","article-title":"Exploring endolysin-loaded alginate-chitosan nanoparticles as future remedy for staphylococcal infections","volume":"21","author":"Kaur","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/bs.apha.2026.03.002_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12070661","article-title":"Conjugation of therapeutic psd-95 inhibitors to the cell-penetrating peptide tat affects blood\u2013brain barrier adherence, uptake, and permeation","volume":"12","author":"Kristensen","year":"2020","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/bs.apha.2026.03.002_bib47","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/acs.jpcb.2c06751","article-title":"Peptide self-assembled nanocarriers for cancer drug delivery","volume":"127","author":"Kumar","year":"2023","journal-title":"Journal of Physical Chemistry B"},{"key":"10.1016\/bs.apha.2026.03.002_bib48","doi-asserted-by":"crossref","unstructured":"Kurihara, A., Pardridge, W.M., Angeles, L., & Dtpa, T. (2000). 111 In peptide radiopharmaceuticals for brain amyloid imaging: chelation, conjugation to poly (ethylene glycol)-biotin linkers, and autoradiography with Alzheimer\u2019 s disease brain sections, 2000, 380\u2013386.","DOI":"10.1021\/bc9901393"},{"key":"10.1016\/bs.apha.2026.03.002_bib49","article-title":"Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo","volume":"23","author":"Lakkadwala","year":"2020","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.002_bib50","first-page":"1","article-title":"An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a","volume":"28","author":"Lee","year":"2017","journal-title":"Korean Gynecologic Oncology Group study (KGOG-3016"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12989-019-0307-3","article-title":"Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery","volume":"16","author":"Leite","year":"2019","journal-title":"Particle and Fibre Toxicology"},{"issue":"25","key":"10.1016\/bs.apha.2026.03.002_bib52","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/bs.apha.2026.03.002_bib53","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/bc400055h","article-title":"B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide","volume":"24","author":"Liu","year":"2013","journal-title":"Bioconjugate Chemistry"},{"issue":"15","key":"10.1016\/bs.apha.2026.03.002_bib54","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"issue":"866","key":"10.1016\/bs.apha.2026.03.002_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3762\/bjnano.11.72","article-title":"Key for crossing the BBB with nanoparticles: The rational design","volume":"11","author":"Lombardo","year":"2020","journal-title":"Beilstein Journal of Nanotechnology"},{"issue":"December 2019","key":"10.1016\/bs.apha.2026.03.002_bib56","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/bs.apha.2026.03.002_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113774","article-title":"Hierarchical design of hyaluronic acid-peptide constructs for glioblastoma targeting: Combining insights from NMR and molecular dynamics simulations","volume":"315","author":"Mendes","year":"2020","journal-title":"Journal of Molecular Liquids"},{"issue":"5991","key":"10.1016\/bs.apha.2026.03.002_bib58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.329.5991.502","article-title":"Is pharma running out of brainy ideas?","volume":"329","author":"Miller","year":"2010","journal-title":"Science (New York, N. Y.)"},{"issue":"December 2021","key":"10.1016\/bs.apha.2026.03.002_bib59","article-title":"Comparison of three synthetic transferrin mimetic small peptides to promote the blood\u2013brain barrier penetration of vincristine liposomes for improved glioma targeted therapy","volume":"613","author":"Mojarad-Jabali","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"issue":"August","key":"10.1016\/bs.apha.2026.03.002_bib60","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresbull.2018.08.003","article-title":"Ligand conjugation: An emerging platform for enhanced brain drug delivery","volume":"142","author":"Nabi","year":"2018","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.apha.2026.03.002_bib61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijbiomac.2013.04.024","article-title":"Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety","volume":"59","author":"Nagpal","year":"2013","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in clinical trials: Analysis of clinical trials, FDA approvals and use for COVID-19 vaccines","volume":"24","author":"Namiot","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2026.03.002_bib63","doi-asserted-by":"crossref","unstructured":"Hanumanthappa, R., Heggannavar, G. B., Banakar, A., Achari, D. D., Karoshi, V. R., Krushna, B. R. R., ... Devaraju, K. S. (2025). A levodopa-encapsulated poly-\u03b5-caprolactone nanocomposite improves the motor symptoms and neurochemical changes in a rotenone-induced mouse model of Parkinson\u2019s disease. ACS Omega, 10(19), 19682\u201319696. https:\/\/doi.org\/10.1021\/acsomega.5c00691.","DOI":"10.1021\/acsomega.5c00691"},{"key":"10.1016\/bs.apha.2026.03.002_bib64","unstructured":"NIH National Library of Medicine, N. C. for B. I. (opens in a new tab). (n.d.). ClinicalTrials.gov."},{"issue":"7","key":"10.1016\/bs.apha.2026.03.002_bib65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.002_bib66","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.bmc.2017.08.031","article-title":"Improving oral bioavailability of cyclic peptides by N-methylation","volume":"26","author":"R\u00e4der","year":"2018","journal-title":"Bioorganic and Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14020247","article-title":"The Hitchhiker\u2019s guide to human therapeutic nanoparticle development","volume":"14","author":"Ramos","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/bs.apha.2026.03.002_bib68","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/17435889.2.3.345","article-title":"Ethics in nanomedicine","volume":"2","author":"Resnik","year":"2007","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2026.03.002_bib69","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/acs.molpharmaceut.0c00218","article-title":"Nerve growth factor gene delivery across the blood-brain barrier to reduce beta amyloid accumulation in AD mice","volume":"17","author":"Rodrigues","year":"2020","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/cbr.2009.0627","article-title":"Affinity and avidity in antibody-based tumor targeting","volume":"24","author":"Rudnick","year":"2009","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"issue":"11","key":"10.1016\/bs.apha.2026.03.002_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05495","article-title":"Physical characterization of chitosan\/gelatin-alginate composite beads for controlled release of urea","volume":"6","author":"Sathisaran","year":"2020","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/bs.apha.2026.03.002_bib72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/cpr.12192","article-title":"Independent effect of polymeric nanoparticle zeta potential\/surface charge, on their cytotoxicity and affinity to cells","volume":"48","author":"Shao","year":"2015","journal-title":"Cell Proliferation"},{"issue":"4","key":"10.1016\/bs.apha.2026.03.002_bib73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40139-021-00227-z","article-title":"Toxicology of nanoparticles in drug delivery","volume":"9","author":"Sharma","year":"2021","journal-title":"Current Pathobiology Reports"},{"issue":"5","key":"10.1016\/bs.apha.2026.03.002_bib74","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1039\/C9BM01750J","article-title":"Angiopep-2 conjugated nanoparticles loaded with doxorubicin for the treatment of primary central nervous system lymphoma","volume":"8","author":"Shi","year":"2020","journal-title":"Biomaterials Science"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.002_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0139652","article-title":"Cell-penetrating peptides selectively cross the blood-brain barrier in vivo","volume":"10","author":"Stalmans","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.apha.2026.03.002_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-025-00641-0","article-title":"PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier","volume":"22","author":"Szecsk\u00f3","year":"2025","journal-title":"Fluids and Barriers of the CNS"},{"issue":"2","key":"10.1016\/bs.apha.2026.03.002_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24020351","article-title":"Peptide-based drug-delivery systems in biotechnological applications: Recent advances and perspectives","volume":"24","author":"Tesauro","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"August","key":"10.1016\/bs.apha.2026.03.002_bib78","first-page":"1","article-title":"Targeted propolis-loaded poly (butyl) cyanoacrylate nanoparticles: An alternative drug delivery tool for the treatment of cryptococcal meningitis","volume":"12","author":"Thammasit","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2026.03.002_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cobeha.2015.11.013","article-title":"Insulin-like peptides signaling in Alzheimer\u2019s disease: On the road to alternative therapeutics","volume":"9","author":"Trueba-Saiz","year":"2016","journal-title":"Current Opinion in Behavioral Sciences"},{"key":"10.1016\/bs.apha.2026.03.002_bib80","first-page":"609","article-title":"Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery","volume":"10","author":"Vasconcelos","year":"2015","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.apha.2026.03.002_bib81","series-title":"Seaweed polysaccharides: Isolation, biological and biomedical applications","article-title":"Preparations and applications of alginate nanoparticles","author":"Venkatesan","year":"2017"},{"issue":"March","key":"10.1016\/bs.apha.2026.03.002_bib82","first-page":"1","article-title":"Nano-neurotheranostics: Impact of nanoparticles on neural dysfunctions and strategies to reduce toxicity for improved efficacy","volume":"12","author":"Vinod","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2026.03.002_bib83","first-page":"765","article-title":"Recent advances of chitosan nanoparticles as drug carriers","volume":"6","author":"Wang","year":"2011","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.apha.2026.03.002_bib84","doi-asserted-by":"crossref","DOI":"10.1021\/mp500393m","article-title":"Apamin-mediated actively targeted drug delivery for treatment of spinal cord injury: More than just a concept","author":"Wu","year":"2014","journal-title":"Molecular Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2026.03.002_bib85","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijpharm.2012.07.029","article-title":"Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery","volume":"436","author":"Xia","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"issue":"32","key":"10.1016\/bs.apha.2026.03.002_bib86","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1016\/j.biomaterials.2012.07.046","article-title":"Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles","volume":"33","author":"Xin","year":"2012","journal-title":"Biomaterials"},{"issue":"August","key":"10.1016\/bs.apha.2026.03.002_bib87","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.2147\/IJN.S318266","article-title":"Efficient anti-glioma therapy through the brain-targeted RVG15-modified liposomes loading paclitaxel-cholesterol complex","volume":"16","author":"Xin","year":"2021","journal-title":"International Journal of Nanomedicine"},{"issue":"8","key":"10.1016\/bs.apha.2026.03.002_bib88","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Xu","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/bs.apha.2026.03.002_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mco2.327","article-title":"Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2023","journal-title":"MedComm"},{"issue":"14","key":"10.1016\/bs.apha.2026.03.002_bib90","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.7150\/thno.42234","article-title":"BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/bs.apha.2026.03.002_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202003937","article-title":"Development of polymeric nanoparticles for blood\u2013brain barrier transfer\u2014strategies and challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Advanced Science"},{"key":"10.1016\/bs.apha.2026.03.002_bib92","article-title":"Optimizing Angiopep-2 density on polymeric nanoparticles for enhanced blood-brain barrier penetration and glioblastoma targeting: Insights from in vitro and in vivo experiments","author":"Zhang","year":"2025","journal-title":"Advanced Functional Materials"},{"key":"10.1016\/bs.apha.2026.03.002_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10395","article-title":"Targeted brain delivery of RVG29-modified rifampicin-loaded nanoparticles for Alzheimer\u2019 s disease treatment and diagnosis","author":"Zhou","year":"2022","journal-title":"Bioengineering & Translational Medicine"},{"key":"10.1016\/bs.apha.2026.03.002_bib94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"Journal of Controlled Release"}],"container-title":["Advances in Pharmacology","Brain Shuttle Peptides: Development and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:22:24Z","timestamp":1783185744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358926000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443415470"],"references-count":94,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2026.03.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}